Tolga Uz

556 total citations
18 papers, 440 citations indexed

About

Tolga Uz is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tolga Uz has authored 18 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tolga Uz's work include Phosphodiesterase function and regulation (10 papers), Receptor Mechanisms and Signaling (9 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Tolga Uz is often cited by papers focused on Phosphodiesterase function and regulation (10 papers), Receptor Mechanisms and Signaling (9 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Tolga Uz collaborates with scholars based in United States, United Kingdom and Netherlands. Tolga Uz's co-authors include Hari Manev, Anke Sambeth, Jos Prickaerts, Arjan Blokland, Pim R.A. Heckman, Marlies A. van Duinen, Max Tsai, Jin‐Yang Joo, Tim Vanmierlo and Jochen De Vry and has published in prestigious journals such as NeuroImage, Neuropsychopharmacology and Psychopharmacology.

In The Last Decade

Tolga Uz

17 papers receiving 433 citations

Peers

Countries citing papers authored by Tolga Uz

Since Specialization

Citations

This map shows the geographic impact of Tolga Uz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tolga Uz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tolga Uz more than expected).

Fields of papers citing papers by Tolga Uz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tolga Uz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tolga Uz. The network helps show where Tolga Uz may publish in the future.

Co-authorship network of co-authors of Tolga Uz

This figure shows the co-authorship network connecting the top 25 collaborators of Tolga Uz. A scholar is included among the top collaborators of Tolga Uz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tolga Uz. Tolga Uz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [11C]PHNO PET 2021 ·Neuropsychopharmacology ·Eugenii A. Rabiner, Tolga Uz, Ayla Mansur, Terry Brown, Grace Chen, Jingtao Wu, (unknown), Adam J. Schwarz, Wei Yin, Yvonne Lewis, Graham E. Searle, (unknown), Jan Passchier, Roger N. Gunn, J. Tauscher	12
2	MITOCHONDRIAL DISEASES 2021 ·Neuromuscular Disorders ·(unknown), (unknown), (unknown), (unknown), Erik Kelly, Stephen R. Doyle, Tolga Uz, Amel Karaa	0
3	Single‐ and multiple‐dose safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of ASP0367, or bocidelpar sulfate, a novel modulator of peroxisome proliferator‐activated receptor delta in healthy adults: Results from a phase 1 study 2021 ·Muscle & Nerve ·(unknown), Sitra Tauscher‐Wisniewski, Ronald Smulders, (unknown), Akihiro Yamada, (unknown), Tolga Uz, Gerard J. Marek, Ronald Goldwater	4
4	Phase 1 randomized study on the safety, tolerability, and pharmacodynamic cognitive and electrophysiological effects of a dopamine D1 receptor positive allosteric modulator in patients with schizophrenia 2020 ·Neuropsychopharmacology ·Amit Desai, (unknown), (unknown), Lev Gertsik, Paul Maruff, Gregory A. Light, Tolga Uz, Gerard J. Marek, Tong Zhu	11
5	Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies 2020 ·Clinical Pharmacokinetics ·Amit Desai, (unknown), (unknown), Lev Gertsik, Tolga Uz, Gerard J. Marek, Tong Zhu	3
6	The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial 2020 ·Journal of Psychopharmacology ·James Gilleen, Judith Nottage, (unknown), (unknown), (unknown), Tolga Uz, (unknown), Max Tsai, (unknown), Steven Williams, Dominic ffytche, Mitul A. Mehta, Sukhwinder S. Shergill	17
7	Acute treatment with the PDE4 inhibitor roflumilast improves verbal word memory in healthy old individuals: a double-blind placebo-controlled study 2019 ·Neurobiology of Aging ·Arjan Blokland, Marlies A. van Duinen, Anke Sambeth, Pim R.A. Heckman, Max Tsai, Gëzim Lahu, Tolga Uz, Jos Prickaerts	49
8	A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects 2019 ·Psychopharmacology ·Deborah Yurgelun‐Todd, Perry F. Renshaw, Paul Goldsmith, Tolga Uz, Thomas A. Macek	9
9	An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients 2018 ·Psychopharmacology ·James Gilleen, (unknown), (unknown), (unknown), (unknown), Tolga Uz, (unknown), Max Tsai, (unknown), Avi Reichenberg, Steven Williams, Mitul A. Mehta, Sukhwinder S. Shergill	41
10	A Nonhuman Primate PET Study: Measurement of Brain PDE4 Occupancy by Roflumilast Using (R)-[11C]Rolipram 2018 ·Molecular Imaging and Biology ·Akihiro Takano, Tolga Uz, (unknown), Max Tsai, Gëzim Lahu, Nahid Amini, Ryuji Nakao, Zhisheng Jia, Christer Halldin	11
11	Acute administration of roflumilast enhances immediate recall of verbal word memory in healthy young adults 2017 ·Neuropharmacology ·Marlies A. van Duinen, Anke Sambeth, Pim R.A. Heckman, (unknown), Ming‐Daw Tsai, (unknown), Tolga Uz, Arjan Blokland, Jos Prickaerts	45
12	Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial 2017 ·Psychopharmacology ·Pim R.A. Heckman, Marlies A. van Duinen, Arjan Blokland, Tolga Uz, Jos Prickaerts, Anke Sambeth	15
13	The PDE4-inhibitor roflumilast improves memory: findings from a translational perspective 2017 ·European Neuropsychopharmacology ·Marlies A. van Duinen, Anke Sambeth, Pim R.A. Heckman, Ming‐Daw Tsai, (unknown), Tolga Uz, Arjan Blokland, Jos Prickaerts	5
14	The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses 2016 ·Behavioural Brain Research ·Tim Vanmierlo, (unknown), Sven Akkerman, Marlies van Duinen, Anke Sambeth, Jochen De Vry, Tolga Uz, Arjan Blokland, Jos Prickaerts	93
15	A human [ 11 C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor 2016 ·NeuroImage ·Akihiro Takano, Per Stenkrona, В. А. Степанов, Nahid Amini, (unknown), Max Tsai, Paul Goldsmith, (unknown), Jingtao Wu, Tolga Uz, Christer Halldin, Thomas A. Macek	22
16	Prolonged swim‐test immobility of serotonin N‐acetyltransferase (AANAT)‐mutant mice 2001 ·Journal of Pineal Research ·Tolga Uz, Hari Manev	25
17	Circadian expression of pineal 5-lipoxygenase mRNA 1998 ·Neuroreport ·Tolga Uz, Hari Manev	35
18	Opposite effects of pinealectomy and melatonin administration on brain damage following cerebral focal ischemia in rat 1998 ·Restorative Neurology and Neuroscience ·Jin‐Yang Joo, Tolga Uz, Hari Manev	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact